$LRHC
La Rosa Holdings Corp. Stock $lrhc

$lrhc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000157587223001807 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q2
Revenue	$11.44M	$6.792M	$7.490M
YoY Change	90.65%	10.77%	0.67%
Cost Of Revenue	$10.47M	$6.217M	$6.820M
YoY Change	84.3%	11.36%	1.34%
Gross Profit	$970.7K	$575.5K	$670.0K
YoY Change	203.35%	4.78%	-5.63%
Gross Profit Margin	8.49%	8.47%	8.95%
Selling, General & Admin	$6.939M	$993.0K	$960.0K
YoY Change	567.24%	-16.28%	-17.95%
% of Gross Profit	714.85%	172.54%	143.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$73.13K
YoY Change
% of Gross Profit	7.53%
Operating Expenses	$6.939M	$993.0K	$960.0K
YoY Change	567.24%	-16.28%	-17.95%
Operating Profit	-$5.969M	-$417.5K	-$290.0K
YoY Change	728.96%	-34.45%	-36.96%
Interest Expense	-$126.7K	-$204.7K	-$110.0K
YoY Change	-69.09%	241.08%	175.0%
% of Operating Profit
Other Income/Expense, Net	$7.810K	$73.61K	$0.00
YoY Change	-126.03%	-232.52%	-100.0%
Pretax Income	-$6.087M	-$343.8K	-$400.0K
YoY Change	424.78%	-50.34%	21.21%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$7.555M	-$343.8K	-$400.0K
YoY Change	647.99%	-50.34%	21.21%
Net Earnings / Revenue	-66.04%	-5.06%	-5.34%
Basic Earnings Per Share		-$0.06	-$0.07
Diluted Earnings Per Share	-$0.69	-$0.06	-$0.03
COMMON SHARES
Basic Shares Outstanding	11.39M	6.181M	6.004M shares
Diluted Shares Outstanding		6.181M	6.004M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$959.6K	$350.3K	$290.0K
YoY Change	699.67%	400.4%	625.0%
Cash & Equivalents	$959.6K	$350.3K	$292.7K
Short-Term Investments
Other Short-Term Assets	$1.484M	$1.547M	$1.540M
YoY Change	3198.27%	19.01%	26.23%
Inventory
Prepaid Expenses
Receivables	$826.4K	$274.2K	$230.0K
Other Receivables	$0.00	$45.41K	$50.00K
Total Short-Term Assets	$3.270M	$2.217M	$2.110M
YoY Change	60.23%	28.9%	30.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$702.5K
YoY Change
Goodwill	$5.703M
YoY Change
Intangibles	$4.632M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$21.27K	$21.27K	$2.180M
YoY Change	-73.18%	-98.65%	4.31%
Total Long-Term Assets	$11.06M	$3.550M	$2.180M
YoY Change	501.1%	124.71%	3.81%
TOTAL ASSETS
Total Short-Term Assets	$3.270M	$2.217M	$2.110M
Total Long-Term Assets	$11.06M	$3.550M	$2.180M
Total Assets	$14.33M	$5.768M	$4.290M
YoY Change	269.23%	74.77%	15.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.147M	$1.217M	$1.280M
YoY Change	-24.73%	-19.38%	5.79%
Accrued Expenses	$868.1K	$608.2K	$700.0K
YoY Change	66.22%	73.78%	180.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$197.0K	$210.0K
YoY Change	-100.0%	-70.15%	-70.42%
Long-Term Debt Due	$4.400K	$253.2K	$480.0K
YoY Change	-98.24%	-12.69%	1100.0%
Total Short-Term Liabilities	$2.097M	$3.083M	$3.410M
YoY Change	-54.85%	-21.94%	-4.75%
LONG-TERM LIABILITIES
Long-Term Debt	$615.1K	$354.5K	$360.0K
YoY Change	70.87%	-4.18%	-2.7%
Other Long-Term Liabilities	$1.850M	$1.607M	$1.550M
YoY Change	5.73%	-11.21%	29.17%
Total Long-Term Liabilities	$2.465M	$1.962M	$1.910M
YoY Change	16.58%	-10.02%	21.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.097M	$3.083M	$3.410M
Total Long-Term Liabilities	$2.465M	$1.962M	$1.910M
Total Liabilities	$8.419M	$5.045M	$5.320M
YoY Change	24.56%	-17.7%	3.3%
SHAREHOLDERS EQUITY
Retained Earnings	-$12.11M	-$6.026M
YoY Change	182.28%
Common Stock	$18.02M	$6.748M
YoY Change	1176.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.910M	$722.5K	-$1.035M
YoY Change
Total Liabilities & Shareholders Equity	$14.33M	$5.768M	$4.290M
YoY Change	269.23%	74.77%	15.32%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	-$7.555M	-$343.8K	-$400.0K
YoY Change	647.99%	-50.34%	21.21%
Depreciation, Depletion And Amortization	$73.13K
YoY Change
Cash From Operating Activities	-$1.444M	-$290.8K	$110.0K
YoY Change	167.34%	-60.17%	0.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$141.7K
YoY Change
Cash From Investing Activities	-$141.7K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.132M	358.3K	-10.00K
YoY Change	204.54%	-57.85%	-97.14%
NET CHANGE
Cash From Operating Activities	-1.444M	-290.8K	110.0K
Cash From Investing Activities	-141.7K
Cash From Financing Activities	2.132M	358.3K	-10.00K
Net Change In Cash	546.4K	67.52K	100.0K
YoY Change	241.49%	-43.73%	-141.67%
FREE CASH FLOW
Cash From Operating Activities	-$1.444M	-$290.8K	$110.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001879403
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Financing Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration FinancingReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q3	us-gaap	Financing Receivable After Allowance For Credit Loss Current Related Party Type Extensible Enumeration FinancingReceivableAfterAllowanceForCreditLossCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q2	lrhc	Stockholders Equity Forward Stock Split StockholdersEquityForwardStockSplit	0.5
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-41588
	dei	Entity Registrant Name EntityRegistrantName	LA ROSA HOLDINGS CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-1641189
	dei	Entity Address Address Line1 EntityAddressAddressLine1	1420 Celebration Blvd.
	dei	Entity Address Address Line2 EntityAddressAddressLine2	2nd Floor
	dei	Entity Address City Or Town EntityAddressCityOrTown	Celebration
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	34747
	dei	City Area Code CityAreaCode	321
	dei	Local Phone Number LocalPhoneNumber	250-1799
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	LRHC
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	11394990
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	350276
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	118558
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1547175
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1411364
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	274210
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	424549
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	45000
CY2023Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	45413
CY2022Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	41558
CY2023Q3	us-gaap	Assets Current AssetsCurrent	2217074
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2041029
CY2023Q3	us-gaap	Deferred Costs DeferredCosts	3529192
CY2022Q4	us-gaap	Deferred Costs DeferredCosts	1760447
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21270
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	79314
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	3550462
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1839761
CY2023Q3	us-gaap	Assets Assets	5767536
CY2022Q4	us-gaap	Assets Assets	3880790
CY2023Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	101991
CY2022Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	86163
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1217318
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1523936
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	608232
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	522279
CY2023Q3	lrhc	Other Notes Payable Related Party One Current OtherNotesPayableRelatedPartyOneCurrent	149245
CY2022Q4	lrhc	Other Notes Payable Related Party One Current OtherNotesPayableRelatedPartyOneCurrent	652233
CY2023Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	323750
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	1022879
CY2023Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	95000
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	585779
CY2023Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	334722
CY2023Q3	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	253200
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	250788
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3083458
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4644057
CY2023Q3	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	354540
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	360912
CY2022Q4	lrhc	Other Long Term Notes Payable Related Party One OtherLongTermNotesPayableRelatedPartyOne	338757
CY2023Q3	lrhc	Security Deposit Payable Current SecurityDepositPayableCurrent	1607024
CY2022Q4	lrhc	Security Deposit Payable Current SecurityDepositPayableCurrent	1415059
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1961564
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2114728
CY2023Q3	us-gaap	Liabilities Liabilities	5045022
CY2022Q4	us-gaap	Liabilities Liabilities	6758785
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6284168
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6284168
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6000000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6000000
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	628
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	600
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6747489
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1410724
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6025603
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4289319
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	722514
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2877995
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5767536
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3880790
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6792250
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6131892
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20320606
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20206673
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	6216751
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	5582663
	us-gaap	Cost Of Revenue CostOfRevenue	18450162
	us-gaap	Cost Of Revenue CostOfRevenue	17998181
CY2023Q3	us-gaap	Gross Profit GrossProfit	575499
CY2022Q3	us-gaap	Gross Profit GrossProfit	549229
	us-gaap	Gross Profit GrossProfit	1870444
	us-gaap	Gross Profit GrossProfit	2208492
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	943675
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1133987
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2751713
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3195947
CY2023Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	49277
CY2022Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	52057
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	242548
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	296429
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	992952
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1186044
	us-gaap	Operating Expenses OperatingExpenses	2994261
	us-gaap	Operating Expenses OperatingExpenses	3492376
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-417453
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-636815
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1123817
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1283884
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	6966
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	50351
	us-gaap	Interest Expense Debt InterestExpenseDebt	147505
	us-gaap	Interest Expense Debt InterestExpenseDebt	84020
CY2023Q3	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	207887
CY2022Q3	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	4053
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	882781
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	100123
CY2023Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-10201
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1147
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-138985
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	24363
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	149312
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	278266
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	278834
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27786
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	73614
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-55551
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-612467
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-31408
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-343839
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-692366
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1736284
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1315292
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-343839
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-692366
	us-gaap	Net Income Loss NetIncomeLoss	-1736284
	us-gaap	Net Income Loss NetIncomeLoss	-1315292
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6180633
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6180633
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6000000
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6000000
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6063056
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6063056
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6000000
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6000000
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1035083
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-343839
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	600000
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1250840
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5041
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	722514
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-2877995
	us-gaap	Net Income Loss NetIncomeLoss	-1736284
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3446468
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	1250840
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	150000
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	79341
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	722514
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-2148132
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-692366
CY2022Q3	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Paid DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsPaid	11660
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2828838
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1313519
	us-gaap	Net Income Loss NetIncomeLoss	-1315292
	us-gaap	Distribution Made To Limited Liability Company Llc Member Cash Distributions Declared DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared	200027
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2828838
	us-gaap	Net Income Loss NetIncomeLoss	-1736284
	us-gaap	Net Income Loss NetIncomeLoss	-1315292
	us-gaap	Share Based Compensation ShareBasedCompensation	79341
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	149312
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-138985
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	24363
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	714961
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	100123
	us-gaap	Paid In Kind Interest PaidInKindInterest	56877
	us-gaap	Paid In Kind Interest PaidInKindInterest	69147
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	212358
	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	17826
	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	74817
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-132513
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-225771
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-45000
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5000
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-171370
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3049
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	145013
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	201057
	lrhc	Increase Decrease In Securities Deposit Payable Current IncreaseDecreaseInSecuritiesDepositPayableCurrent	191965
	lrhc	Increase Decrease In Securities Deposit Payable Current IncreaseDecreaseInSecuritiesDepositPayableCurrent	183553
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	51136
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-450785
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-644958
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	293523
	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	21518
	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	277695
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	264448
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	280951
	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	500650
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	326250
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	595108
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	375182
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	20000
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	670000
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	18855
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	33136
	us-gaap	Proceeds From Issuance Of Convertible Preferred Stock ProceedsFromIssuanceOfConvertiblePreferredStock	1523000
	us-gaap	Payments Of Dividends PaymentsOfDividends	200027
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	818314
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	367621
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	367529
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-277337
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1529922
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1639798
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1897451
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1362461
	us-gaap	Interest Paid Net InterestPaidNet	22386
	us-gaap	Interest Paid Net InterestPaidNet	14873
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1923468
	lrhc	Deferred Offered Costs Incurred Paid During The Period DeferredOfferedCostsIncurredPaidDuringThePeriod	-77204
	lrhc	Deferred Offered Costs Incurred Paid During The Period DeferredOfferedCostsIncurredPaidDuringThePeriod	579439
	us-gaap	Stock Issued1 StockIssued1	1250840
	lrhc	Issuance Of Shares Of Common Stock As Part Of The Repayment Of Note IssuanceOfSharesOfCommonStockAsPartOfTheRepaymentOfNote	150000
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	410144
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	350276
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	66961
CY2023Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1547175
CY2022Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	1295500
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1897451
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1362461
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">NOTE 1 - DESCRIPTION OF BUSINESS AND NATURE OF OPERATIONS</div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.4in; text-align: justify; text-indent: -0.2in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.4in; text-align: justify; text-indent: -0.2in; line-height: 12pt; background: none;"><div style="white-space:pre-line; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Nature of Organization </div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">La Rosa Holdings Corp. (the “Company”) is the holding company for five agent-centric, technology-integrated, cloud-based, multi-service real estate </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">segments</div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">. In addition to providing person-to-person residential and commercial real estate brokerage services to the public, the Company cross sells ancillary technology-based products and services primarily to sales agents and the sales agents associated with the Company’s franchisees. The business is organized based on the services provided internally to agents and to the public, which are residential and commercial real estate brokerages, franchising, real estate brokerage education and coaching, and property management services.</div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.4in; text-align: justify; text-indent: -0.2in; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.2in; text-align: justify; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space:pre-line; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Liquidity </div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the first nine months of fiscal year 2023, the Company effectuated a number of transactions that significantly increased the Company’s liquidity since its position on December 31, 2022. The Company issued 1,523 shares of Series A Convertible Preferred Stock to 77 investors in a private placement pursuant to Regulation D under the Securities Act, raising $1,523,000. The Company also exchanged convertible debt with an outstanding balance of $598,836, including accrued interest of $87,836, for 591 shares of Series A Preferred Stock. On March 27, 2023, the Company exchanged a portion of its related party debt with an outstanding gross balance of $1,324,631, excluding debt discount of $469,785, but including accrued interest of $28,101, for 1,321 shares of Series A Preferred Stock. And on December 31, 2022, a loan of $556,268 from Celebration Office Condos LLC, a company owned by Mr. La Rosa, was forgiven for one share of Series A Preferred Stock that was issued in the first quarter of fiscal year 2023. See Note 6 – Equity for additional information on the Series A Convertible Preferred Stock.</div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div> </div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On September 30, 2023, the Company had a cash balance of $350,276 and negative working capital of ($866,384). On October 12, 2023, the Company completed an initial public offering (“IPO”) and sold 1,000,000 shares of its common stock, par value $0.0001, at a price to the public of $5.00 per share, resulting in gross proceeds of $5,000,000. The Company received net proceeds of $4,360,000 after underwriter discounts, commissions, and expenses. The Company also reclassified $3,529,192 of deferred offering costs as of September 30, 202<div style="letter-spacing: 0px; top: 0px;;display:inline;">3</div> to additional paid in capital upon completing the IPO. The Company used the proceeds to </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">satisfy</div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> existing debt and accrued interest </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">in the aggregate amount </div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">of approximately $375,000, related party debt of approximately $150,000, <div style="letter-spacing: 0px; top: 0px;;display:inline;">and </div>existing accounts payable of $1,000,000</div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">., On October 13, 2023 and on October 16, 2023, the Company acquired controlling interests in two of its franchisees: Horeb Kissimmee Realty, LLC and La Rosa Realty Lake Nona, Inc., for a total consideration of $4,743,127, including $550,000 in cash from the proceeds of the IPO, with the remainder in common stock. See Note 8 – Subsequent Events for additional information regarding the acquisitions.</div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); text-decoration: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company is subject to the risks and challenges associated with companies at a similar stage of development. These include dependence on key individuals, successful development and marketing of its offerings, and competition with larger companies with greater financial, technical, and marketing resources. Furthermore, during the period required to achieve substantially higher revenue in order to become consistently profitable, the Company may require additional funds that might not be readily available or might not be on terms that are acceptable to the Company. Until such time that the Company implements its growth strategy, it expects to continue to generate operating losses in the foreseeable future, mostly due to corporate overhead and costs of being a public company. The Company believes that its existing working capital and cash on hand<div style="letter-spacing: 0px; top: 0px;;display:inline;"> after completing its IPO </div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> will provide sufficient cash to enable the Company to meet its operating needs and debt requirements for the next twelve months from the issuance date of this report.</div></div>
CY2023Q3	us-gaap	Cash Cash	350276
CY2023Q3	lrhc	Net Current Assets NetCurrentAssets	-866384
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-10
CY2023Q2	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	2-for-1
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.13in; text-align: justify; line-height: 12pt; background: none;"><div style="font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates</div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;"><div style="font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the Company’s condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s significant estimates include allowance for doubtful accounts and assumptions used to determine fair value of warrants and other equity instruments, the embedded conversion features of the convertible notes, and the fair value of acquisitions, including intangible assets.</div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.4in; text-indent: -0.25in; line-height: 12pt; background: none;"><div style="white-space-collapse: preserve; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.13in; text-align: justify; line-height: 12pt; background: none;"><div style="font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Reclassifications</div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0px 0px 0px 0.5in; text-align: justify; line-height: 12pt; background: none;"><div style="font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Certain reclassifications have been made to data presented in the 2022 financial statements to conform with the 2023 financial statement presentation.</div></div>
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin: 0px 0px 0px 9.35pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none;"><div style="display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Concentrations of Credit Risk</div></div></div><div style="margin: 0px 0px 0px 0.5in; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; background: none;"><div style="display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and trade accounts receivable. Although the Company limits its exposure to credit loss by depositing its cash with established financial institutions that management believes have good credit ratings and represent minimal risk of loss of principal, the Company’s deposits, at times, may exceed federally insured limits. Collateral is not required for accounts receivable, and the Company believes the carrying value approximates fair value.</div></div></div>
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6131892
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	44721
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	29039
CY2023Q3	us-gaap	Deferred Offering Costs DeferredOfferingCosts	3529192
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1760447
CY2023Q3	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	207887
CY2022Q3	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	4053
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	882781
	us-gaap	Debt Related Commitment Fees And Debt Issuance Costs DebtRelatedCommitmentFeesAndDebtIssuanceCosts	100123
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6792250
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20320606
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20206673
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6792250
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6131892
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20320606
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20206673
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	10718
CY2022Q3	us-gaap	Advertising Expense AdvertisingExpense	2780
	us-gaap	Advertising Expense AdvertisingExpense	60032
	us-gaap	Advertising Expense AdvertisingExpense	100921
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	284000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	120000
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	10
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2023Q4	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	149245
CY2023Q3	us-gaap	Notes Payable NotesPayable	607740
CY2022Q4	us-gaap	Notes Payable NotesPayable	611700
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	253200
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	250788
CY2023Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	354540
CY2022Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	360912
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	251059
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	4232
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4232
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	4232
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	4232
CY2023Q3	lrhc	Long Term Debt Maturities Repayments After Year Four LongTermDebtMaturitiesRepaymentsAfterYearFour	339753
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	607740
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	90000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	30000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	5
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	60000
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5
CY2023Q3	us-gaap	Revenues Revenues	6792250
CY2022Q3	us-gaap	Revenues Revenues	6131892
	us-gaap	Revenues Revenues	20320606
	us-gaap	Revenues Revenues	20206673
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6216751
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5582663
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18450162
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17998181
CY2023Q3	us-gaap	Gross Profit GrossProfit	575499
CY2022Q3	us-gaap	Gross Profit GrossProfit	549229
	us-gaap	Gross Profit GrossProfit	1870444
	us-gaap	Gross Profit GrossProfit	2208492
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6792250
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6131892
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20320606
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	20206673

Files In Submission

Name	View Source	Status
lrhc-20230930_lab.xml	Edgar Link	unprocessable
0001575872-23-001807-index-headers.html	Edgar Link	pending
0001575872-23-001807-index.html	Edgar Link	pending
0001575872-23-001807.txt	Edgar Link	pending
0001575872-23-001807-xbrl.zip	Edgar Link	pending
cm444_ex31-1.htm	Edgar Link	pending
cm444_ex31-2.htm	Edgar Link	pending
cm444_ex32-1.htm	Edgar Link	pending
cm444_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lrhc-20230930.htm	Edgar Link	pending
lrhc-20230930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
lrhc-20230930_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lrhc-20230930_def.xml	Edgar Link	unprocessable
lrhc-20230930_pre.xml	Edgar Link	unprocessable
lrhc-20230930_htm.xml	Edgar Link	completed
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LRHC
La Rosa Holdings Corp. Stock $lrhc

2023 Q4 Form 10-Q Financial Statement

#000157587223001807 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LRHC La Rosa Holdings Corp. Stock $lrhc

2023 Q4 Form 10-Q Financial Statement

#000157587223001807 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LRHC
La Rosa Holdings Corp. Stock $lrhc